t-PAI-C marker detection kit and preparation method thereof
A technology for detection kits and markers, which is applied in biological testing, measuring devices, material inspection products, etc., can solve the problems of complex operation, low value repeatability, and low sensitivity, and achieve high detection sensitivity, wide linear range, and specificity. good performance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0011] A method for preparing a t-PAI-C marker detection kit is as follows:
[0012] 1.1. Preparation of calibrator 1:
[0013] The tissue-type plasminogen activator-inhibitor 1 complex was prepared into a calibrator with 1%-5% bovine serum albumin solution, freeze-dried, and assigned, and the prepared concentration was 5 ng / mL.
[0014] 1.2. Preparation of calibrator 2:
[0015] Prepare the tissue-type plasminogen activator-inhibitor 1 complex with 1% to 5% bovine serum albumin solution to make a calibrator and lyophilize it for assignment. The prepared concentration is 50ng / mL
[0016] 1.3. Preparation of Reagent 1
[0017] Take 1 mg tissue-type plasminogen activator-inhibitor 1 complex antibody, and ultrafilter it with PB buffer (pH7.0-8.5) at 4°C or room temperature; the tissue-type plasminogen activator after ultrafiltration - Add 0.05 mg of biotin to the inhibitor 1 complex antibody, and then add PB buffer (pH 7.0-8.5) to make the final antibody concentration 0.05-1 μ...
Embodiment 2
[0027] A method for preparing a t-PAI-C marker detection kit is as follows:
[0028] 2.1. Preparation of calibrator 1:
[0029] The tissue-type plasminogen activator-inhibitor 1 complex was prepared with 1%-5% horse serum albumin solution as a calibrator and freeze-dried for assignment. The concentrations were respectively 5 ng / mL.
[0030] 2.2. Preparation of calibrator 2:
[0031] Prepare the tissue-type plasminogen activator-inhibitor 1 complex with 1% to 5% horse serum albumin solution to make a calibrator and lyophilize it for assignment, the concentration is 50ng / mL
[0032] 2.3. Preparation of reagent 1:
[0033] Take 1 mg tissue-type plasminogen activator-inhibitor 1 complex antibody, and use Tris buffer (pH7.0~8.5) to ultrafilter at 4°C or room temperature; the tissue-type plasminogen activator after ultrafiltration - Add 0.05 mg of biotin to the inhibitor 1 complex antibody, then add Tris buffer (pH 7.0-8.5) to make the final antibody concentration 0.05-1 μg / mL, a...
Embodiment 3
[0042] A method for preparing a t-PAI-C marker detection kit is as follows:
[0043] 3.1. Preparation of calibrator 1:
[0044] The tissue-type plasminogen activator-inhibitor 1 complex was prepared into a calibrator with 1%-5% goat serum albumin solution, freeze-dried, and assigned a concentration of 5 ng / mL.
[0045] 3.2. Preparation of calibrator 2:
[0046] Prepare the tissue-type plasminogen activator-inhibitor 1 complex with 1% to 5% goat serum albumin solution to make a calibrator and lyophilize it for assignment. The prepared concentration is 50ng / mL
[0047] 3.3. Preparation of Reagent 1
[0048] Take 1 mg tissue-type plasminogen activator-inhibitor 1 complex antibody, and ultrafilter it with HEPES buffer (pH7.0-8.5) at 4°C or room temperature; the tissue-type plasminogen activator after ultrafiltration - Add 0.05 mg of biotin to the inhibitor 1 complex antibody, then add HEPES buffer (pH 7.0-8.5) to make the final antibody concentration 0.05-1 μg / mL, and mix for 5...
PUM
Property | Measurement | Unit |
---|---|---|
Sensitivity | aaaaa | aaaaa |
linear range | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
![application no application](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/application.06fe782c.png)
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap